News EMA and FDA agree 'principles' for AI in drug development The FDA and EMA have come up with guiding principles that they say will underpin future guidance on the use of AI technologies in drug development.
News Hippocratic AI builds in life sciences with Grove AI buy Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.
News JPM: Illumina launches 'unprecedented' disease biology atlas Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.
News UK names health data chief, as BIA finds its new CEO Dr Melanie Ivarsson has been appointed head of the UK's new Health Data Research Service, as the BIA selects Prof Chris Molloy as its new CEO.
News JPM: Anthropic reveals its answer to ChatGPT for Health Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.
News NVIDIA announces Lilly, Thermo Fisher collaborations at JPM Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, including a billion dollar partnership with Eli Lilly.
Digital JPM2026: AI diagnostics and translational research, with And... On the sidelines of JPM2026, pharmaphorum spoke with Andrew Beck, co-founder and CEO at PathAI, about AI diagnostics in pathology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.